NOVAVAX INC
Desconocido
PROMISE: Preparing for RSV Immunisation and Surveillance in Europe
NOVAVAX INC
participó en un
H2020:
H2020-JTI-IMI2-2020-22-single-stage
RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progre...
2021-05-21 - 2024-04-30 | Financiado
2021-05-21 - 2024-04-30 | Financiado
RESCEU: REspiratory Syncytial virus Consortium in EUrope Sofia ref. 116019
NOVAVAX INC
participó en un
H2020:
H2020-JTI-IMI2-2015-06-two-stage
RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk gr...
2016-12-14 - 2022-09-30 | Financiado
2016-12-14 - 2022-09-30 | Financiado
* No se disponen de datos de la empresa actual.